SELP and Sepsis: Antiplatelet drugs have an important anti-inflammatory effect, and can reduce C-reactive protein, P-selectin, and leukocyte-platelet aggregates [76,77], and have therefore been proposed as possible targets for sepsis prevention and treatment.